On Sept. 30, hours before the federal government shut down, the U.S. Food and Drug Administration had a baffling act to fit in. The FDA stealthily approved a new generic version of the abortion drug mifepristone.
Mifepristone, a drug the FDA itself admits sends as many as 1 in 25 women to the emergency room even under strict use conditions, is not only responsible for the deaths of countless unborn children, but also has taken the lives of too many mothers along with it.
Ironically, the approval came barely a week after the administration warned pregnant women to reconsider taking Tylenol to avoid harm to their unborn children.